You Searched For: Fmoc-2-aminobutyric+acid

Catalog Number: (BLDPBD295454-250MG)

Supplier: BLD PHARMATECH GMBH

Description: (R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)(methyl)amino)-3-(4-(tert-butoxy)phenyl)propanoic acid 98%

UOM: 1 * 250 mg

Catalog Number: (PRSIXPS-2004)

Supplier: ProSci Inc.

Description: Gamma-aminobutyric acid (GABA) is the primary inhibitory neurotransmitter in the central nervous system, causing a hyperpolarization of the membrane through the opening of a Cl- channel associated with the GABAA-Receptor (GABAA-R) subtype. GABAA-Rs are important therapeutic targets for a range of sedative, anxiolytic, and hypnotic agents and are implicated in several diseases including epilepsy, anxiety, depression, and substance abuse. The GABAA-R is a multimeric subunit complex. To date six alphas, four betas and four gammas, plus alternative splicing variants of some of these subunits, have been identified. Injection in oocytes or mammalian cell lines of cRNA coding for alpha and beta subunits results in the expression of functional GABAA-Rs sensitive to GABA. However, coexpression of a gamma subunit is required for benzodiazepine modulation. The various effects of the benzodiazepines in brain may also be mediated via different alpha subunits of the receptor. Lastly, phosphorylation of beta subunits of the receptor has been shown to modulate GABAA-R function.

UOM: 1 * 100 µl

Catalog Number: (APOSOR61124-500MG)

Supplier: APOLLO SCIENTIFIC

Description: 1-[(tert-Butoxy)carbonyl]-2-{[(9H-fluoren-9-ylmethoxy)carbonyl]amino}piperidine-4-caboxylic acid 95+%

UOM: 1 * 500 mg

Catalog Number: (BLDPBD8592-1000G)

Supplier: BLD PHARMATECH GMBH

Description: 5-tert-Butyl-N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-glutamate hydrate 98%

UOM: 1 * 1.000 g

Catalog Number: (BOSSBS-4234R-A750)

Supplier: Bioss

Description: Catalyses the conversion of gamma-aminobutyrate and L-beta-aminoisobutyrate to succinate semialdehyde and methylmalonate semialdehyde, respectively. Can also convert delta-aminovalerate and beta-alanine.

UOM: 1 * 100 µl

Supplier: Alfa Aesar

Description: Nα-Fmoc-Nω-(2,2,4,6,7-pentamethyl-2,3-dihydrobenzo[b]furan-5-ylsulphonyl)-L-β-homoarginine 95%

Certificates

Catalog Number: (BOSSBS-4234R-CY5)

Supplier: Bioss

Description: Catalyzes the conversion of gamma-aminobutyrate and L-beta-aminoisobutyrate to succinate semialdehyde and methylmalonate semialdehyde, respectively. Can also convert delta-aminovalerate and beta-alanine.

UOM: 1 * 100 µl

Catalog Number: (BLDPBD46697-5G)

Supplier: BLD PHARMATECH GMBH

Description: (2R,2'R)-3,3'-Disulphanediylbis(2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)propanoic acid) 96%

UOM: 1 * 5 g

Catalog Number: (PRSIXPS-2009)

Supplier: ProSci Inc.

Description: Gamma-aminobutyric acid (GABA) is the primary inhibitory neurotransmitter in the central nervous system, causing a hyperpolarization of the membrane through the opening of a Cl- channel associated with the GABAA-Receptor (GABAA-R) subtype. GABAA-Rs are important therapeutic targets for a range of sedative, anxiolytic, and hypnotic agents and are implicated in several diseases including epilepsy, anxiety, depression, and substance abuse. The GABAA-R is a multimeric subunit complex. To date six alphas, four betas and four gammas, plus alternative splicing variants of some of these subunits, have been identified. Injection in oocytes or mammalian cell lines of cRNA coding for alpha and beta subunits results in the expression of functional GABAA-Rs sensitive to GABA. However, coexpression of a gamma subunit is required for benzodiazepine modulation. The various effects of the benzodiazepines in brain may also be mediated via different alpha subunits of the receptor. Lastly, phosphorylation of beta subunits of the receptor has been shown to modulate GABAA-R function.

UOM: 1 * 100 µl

Catalog Number: (BLDPBD217322-250MG)

Supplier: BLD PHARMATECH GMBH

Description: (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-4-((1-(4,4-dimethyl-2,6-dioxocyclohexylidene)-3-methylbutyl)amino)butanoic acid 98%

UOM: 1 * 250 mg

Catalog Number: (PRSIXPS-2005)

Supplier: ProSci Inc.

Description: Gamma-aminobutyric acid (GABA) is the primary inhibitory neurotransmitter in the central nervous system, causing a hyperpolarization of the membrane through the opening of a Cl- channel associated with the GABAA-Receptor (GABAA-R) subtype. GABAA-Rs are important therapeutic targets for a range of sedative, anxiolytic, and hypnotic agents and are implicated in several diseases including epilepsy, anxiety, depression, and substance abuse. The GABAA-R is a multimeric subunit complex. To date six alphas, four betas and four gammas, plus alternative splicing variants of some of these subunits, have been identified. Injection in oocytes or mammalian cell lines of cRNA coding for alpha and beta subunits results in the expression of functional GABAA-Rs sensitive to GABA. However, coexpression of a gamma subunit is required for benzodiazepine modulation. The various effects of the benzodiazepines in brain may also be mediated via different alpha subunits of the receptor. Lastly, phosphorylation of beta subunits of the receptor has been shown to modulate GABAA-R function.

UOM: 1 * 100 µl

Catalog Number: (BLDPBD2005-1G)

Supplier: BLD PHARMATECH GMBH

Description: 2-((5-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-10,11-dihydro-5H-dibenzo[a,d][7]annulen-2-yl)oxy)acetic acid 97%

UOM: 1 * 1 g

Catalog Number: (APOSOR2672-100MG)

Supplier: APOLLO SCIENTIFIC

Description: [4-({[(9H-Fluoren-9-yl)methoxy]carbonyl}amino)tetrahydro-2H-thiopyran-4-yl]acetic acid

UOM: 1 * 100 mg

Catalog Number: (APOSOR2670-1G)

Supplier: APOLLO SCIENTIFIC

Description: [4-({{(9H-Fluoren-9-yl)methoxy]carbonyl}amino)tetrahydro-2H-pyran-4-yl]acetic acid

UOM: 1 * 1 g

Catalog Number: (PRSIXPS-2012)

Supplier: ProSci Inc.

Description: Gamma-aminobutyric acid (GABA) is the primary inhibitory neurotransmitter in the central nervous system, causing a hyperpolarization of the membrane through the opening of a Cl- channel associated with the GABAA-Receptor (GABAA-R) subtype. GABAA-Rs are important therapeutic targets for a range of sedative, anxiolytic, and hypnotic agents and are implicated in several diseases including epilepsy, anxiety, depression, and substance abuse. The GABAA-R is a multimeric subunit complex. To date six alphas, four betas and four gammas, plus alternative splicing variants of some of these subunits, have been identified. Injection in oocytes or mammalian cell lines of cRNA coding for alpha and beta subunits results in the expression of functional GABAA-Rs sensitive to GABA. However, coexpression of a gamma subunit is required for benzodiazepine modulation. The various effects of the benzodiazepines in brain may also be mediated via different alpha subunits of the receptor. Lastly, phosphorylation of beta subunits of the receptor has been shown to modulate GABAA-R function.

UOM: 1 * 100 µl

Catalog Number: (BOSSBS-4234R-A350)

Supplier: Bioss

Description: Catalyzes the conversion of gamma-aminobutyrate and L-beta-aminoisobutyrate to succinate semialdehyde and methylmalonate semialdehyde, respectively. Can also convert delta-aminovalerate and beta-alanine.

UOM: 1 * 100 µl